Abstract
Cryoablation refers to the destruction of tissues by rapid freezing and has been used in the treatment of both metastatic and primary hepatic tumors for several decades. Historically, cryoablation was performed in an open surgical setting and was shown to be an efficacious and generally safe treatment. However, severe but relatively infrequent complications did occur. These early complications led to a better understanding of the biochemistry and predisposing factors that led to the complications. This improved understanding allowed for better patient selection as well as improved post treatment care in avoiding or managing complications. While certain complications, including thrombocytopenia, hemorrhage and cryoshock, are unique to or more common in cryoablation than other ablative modalities, most of these complications are now readily treatable or can be avoided with proper patient screening. Recent technological advances have allowed for cryoablation to be performed percutaneously under imaging guidance. Cryoablation zones are exceptionally well visualized using MR or CT. The precision of cryoablation zone monitoring afforded by CT or MRI guidance provides the operator a degree of intraprocedural confidence regarding ablation zone margins and safety that is not generally possible with other ablation technologies. The placement and powering of individual cryoprobes allows for greater flexibility in avoiding critical structures as well as creating a sufficient ablation zone margin. Cryoablation also causes less pain than radiofrequency ablation, allowing for tumors near the diaphragm, or in a perihepatic location, to be treated with lower doses of intraprocedural and post-procedural analgesic medications. As the stigma of historical problems associated with surgical cryoablation using old technology recedes, a gradually developing body of experience with newer cryoablation technology applied percutaneously and with optimal imaging guidance is stimulating renewed interest in this minimally invasive treatment option for malignant liver tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mala T. Cryoablation of liver tumours – a review of mechanisms, techniques and clinical outcome. Minimal Invasiv Ther. 2006;15:9–17.
Neel HB, Ketcham AS, Hammond WG. Requisites for successful cryogenic surgery of cancer. Arch Surg. 1971;102:45–8.
Stewart GJ, Preketes A, Horton M, Ross WB, Morris DL. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology. 1995;32:215–9.
Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171–86.
Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann Roy Coll Surg Eng. 1984;66:313–8.
Mazur P. The role of intracellular freezing in the death of cells cooled at supraoptimal rates. Cryobiology. 1977;14:251–72.
Gilbert JC, Onik GM, Hoddick WK, et al. Real time ultrasonic monitoring of hepatic cryosurgery. Cryobiology. 1985;22:319–30.
Onik GM. Cryosurgery of liver cancer. Semin Surg Oncol. 1993;9:309–17.
Ravikumar TS, Steele Jr G, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 1991;51:6323–7.
Zhou XD, Tang ZY, Yu YQ, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer: report of 60 cases. Cancer. 1988;61:1889–92.
Wagner JS, Adson MA, Van Heerden AJ, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg. 1984;199:502–7.
Korpan NN. Hepatic cryosurgery for liver metastases: long-term follow-up. Ann Surg. 1997;225:193–201.
Pearson AS, Frencesco I, Fleming D, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–8.
Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23:109–14.
Ruers TJM, Joosten J, Jager GJ, Wobbes J. Long-term results of treating hepatic colorectal metastases with cryosurgery. Brit J Surg. 2001;88:844–9.
Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg. 2000;135:657–64.
Kerkar S, Carlin AM, Sohn RL, et al. Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors. Surgery. 2004;136:770–9.
Nair RT, Silverman SG, Tuncali K, Obuchowski NA, VanSonnenberg E, Shankar S. Biochemical and hematologic alteration following percutaneous cryoablation of liver tumors: experience in 48 procedures. Radiology. 2008;248:303–11.
Pistorious GA, Alexander C, Krisch CM, et al. Local platelet trapping as the cause of thrombocytopenia after hepatic cryotherapy. World J Surg. 2005;29:657–61.
Cozzi PJ, Stewart GJ, Morris DL. Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury. World J Surg. 1994;18:774–6.
Sohn RL, Carlin AM, Steffes C, et al. The extent of cryosurgery increases the complication rate after hepatic cryoablation. Am Surg. 2003;69:317–22.
Wong WS, Patel SC, Cruz FS, Gala DV, Turner AF. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma. Cancer. 1998;82:1268–78.
Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours: a practical guide. HPB Surg. 1995;8:167–73.
Adam R, Majno P, Castaing D, et al. Treatment of irresectable liver tumours by percutaneous cryosurgery. Br J Surg. 1998;85:1493–4.
Silverman SG, Tuncali K, Morrison PR. MR imaging-guided percutaneous tumor ablation. Acad Radiol. 2005;12:1100–9.
Hinshaw JL, Lee FT. Cryoablation for liver cancer. Tech Vasc Interv Rad. 2007;10:47–57.
Permpongkosol S, Nicol TL, Khurana H, et al. Thermal maps around two adjacent cryoprobes creating overlapping ablations in porcine liver, lung and kidney. J Vasc Interv Radiol (JVIR). 2007;18:283–7.
O’Rourke AP, Haemmerich D, Prakash P, Converse MC, Mahvi DM, Webster JG. Current status of liver ablation devices. Expert Rev Med Devices. 2007;4:523–37.
Silverman SG, Sun MR, Tuncali K, et al. Three dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol. 2004;183:707–12.
Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology. 2000;217:657–64.
Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation- initial observations. Radiology. 2005;237:366–70.
Tatli S, Acar M, Tuncali K, Morrison PR, Silverman SG. Percutaneous cryoablation techniques and clinical applications. Diagn Interv Radiol. 2010;16:90–5.
Soloman LA, Munkarah AR, Vorugu VR, et al. Image-guided percutaneous cryotherapy for the management of gynecologic cancer metastases. Gynecol Oncol. 2008;111:202–7.
Xu KC, Niu LZ, He WB, et al. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. World J Gastroenterol. 2003;9:2686–9.
Xu KC, Niu LZ, He WB, Hu YZ, Zuo JS. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol. 2008;14:1430–6.
Xu KJ, Niu LZ, Zhou Q, et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol. 2009;15:3664–9.
Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332–9.
Shock SA, Laeseke PF, Sampson LA, et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology. 2005;236:125–31.
Adam RA, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg. 1997;225:39–50.
Wang H, Littrup PJ, Duan Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–98.
McLoughlin RF, Saliken JF, McKinnon G, Wiseman D, Temple W. CT of the liver after cryotherapy of hepatic metastases: imaging findings. AJR Am J Roentgenol. 1995;165:329–32.
Tacke J, Adam G, Haage P, Sellhaus B, Grobkortenhaus S, Gunther RW. MR-guided percutaneous cryotherapy of the liver: in vivo evaluation with histologic correlation in an animal model. J Magn Reson Imaging (JMRI). 2001;13:50–6.
Kuszyk BS, Boitnott JK, Choti MA, et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology. 2000;217:477–86.
Porter CA, Woodrum DA, Callstrom MR, et al. MRI after technically successful renal cryoablation: early contrast enhancement as a common finding. AJR Am J Roentgenol. 2010;194:790–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Hutchinson, M.J., Shyn, P.B., Silverman, S.G. (2013). Cryoablation of Liver Tumors. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_35
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0751-6_35
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0750-9
Online ISBN: 978-1-4419-0751-6
eBook Packages: MedicineReference Module Medicine